Adverse Events and Oncotargeted Kinase Inhibitors gathers and evaluates data on adverse events associated with tyrosine kinase inhibitors (TKIs), a powerful anti-tumor drug class that has recently been introduced for human therapy. This book compiles...
Price history
▲131.86%
Jan 27, 2022
€189.54
▼-0.02%
Jan 26, 2022
€81.75
▲1.39%
Jan 24, 2022
€81.77
▲1.82%
Jan 17, 2022
€80.65
▲0.01%
Jan 11, 2022
€79.21
▼-0.69%
Jan 10, 2022
€79.20
▲1.35%
Jan 4, 2022
€79.75
▲0.39%
Dec 28, 2021
€78.69
▼-1.45%
Dec 21, 2021
€78.38
▲0.01%
Dec 14, 2021
€79.54